12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Esperion completes IPO

Esperion Therapeutics Inc. (NASDAQ:ESPR), Plymouth, Mich.
Business: Endocrine/Metabolic, Cardiovascular
Date completed: 6/26/13...

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >